B-cell prolymphocytic leukemia successfully treated with B-cell receptor antagonists, but resistant to venetoclax

Leuk Lymphoma. 2020 Mar;61(3):749-752. doi: 10.1080/10428194.2019.1689392. Epub 2019 Nov 12.

Authors

Anna Christoforidou¹, Zoe Bezirgiannidou¹, George Vrachiolias¹, Menelaos Papoutselis¹, Emmanouil Spanoudakis¹, Ιoannis Kotsianidis¹

Affiliation

¹ Department of Haematology, Democritus University of Thrace, Alexandroupolis, Greece.

PMID: 31713446
DOI: 10.1080/10428194.2019.1689392

No abstract available

Publication types

Letter

MeSH terms

Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
Humans
Leukemia, Prolymphocytic*
Leukemia, Prolymphocytic, B-Cell*
Receptors, Antigen, B-Cell
Sulfonamides / therapeutic use

Substances

Bridged Bicyclo Compounds, Heterocyclic
Receptors, Antigen, B-Cell
Sulfonamides
venetoclax